|
Name |
Octacosane
|
Molecular Formula | C28H58 | |
IUPAC Name* |
octacosane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C28H58/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-28H2,1-2H3
|
|
InChIKey |
ZYURHZPYMFLWSH-UHFFFAOYSA-N
|
|
Synonyms |
OCTACOSANE; n-Octacosane; 630-02-4; n-Octcosane; Octacosane, n-; CH3-[CH2]26-CH3; VFF49836P8; NSC-5549; n-Octacosane 1000 microg/mL in Methanol; Octacosane 1000 microg/mL in Dichloromethane; Octacosane, analytical standard; CCRIS 680; UNII-VFF49836P8; NSC 5549; EINECS 211-125-7; Octacosane, 99%; MFCD00009355; AI3-52615; DTXSID6058639; CHEBI:32943; HSDB 8358; NSC5549; ZINC6920420; LMFA11000580; STL453125; AKOS015902504; DB-054367; CS-0317451; FT-0632672; O0002; D91782; 630O024; Q3348776; E66BE919-93E8-4101-AB46-9612FE796394
|
|
CAS | 630-02-4 | |
PubChem CID | 12408 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 394.8 | ALogp: | 14.8 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 25 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 28 | QED Weighted: | 0.109 |
Caco-2 Permeability: | -5.341 | MDCK Permeability: | 0.00000297 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.07 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 100.87% |
Volume Distribution (VD): | 5.296 | Fu: | 0.76% |
CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.128 |
CYP2C19-inhibitor: | 0.11 | CYP2C19-substrate: | 0.053 |
CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.976 |
CYP2D6-inhibitor: | 0.047 | CYP2D6-substrate: | 0.015 |
CYP3A4-inhibitor: | 0.131 | CYP3A4-substrate: | 0.012 |
Clearance (CL): | 4.283 | Half-life (T1/2): | 0.007 |
hERG Blockers: | 0.482 | Human Hepatotoxicity (H-HT): | 0.004 |
Drug-inuced Liver Injury (DILI): | 0.465 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.047 |
Skin Sensitization: | 0.979 | Carcinogencity: | 0.015 |
Eye Corrosion: | 0.997 | Eye Irritation: | 0.925 |
Respiratory Toxicity: | 0.196 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000436 | 0.965 | D00AOJ | 0.713 | ||||
ENC000401 | 0.963 | D00STJ | 0.441 | ||||
ENC000443 | 0.932 | D07ILQ | 0.434 | ||||
ENC000434 | 0.927 | D00FGR | 0.427 | ||||
ENC000437 | 0.901 | D0Z5SM | 0.388 | ||||
ENC000433 | 0.890 | D0Z1QC | 0.340 | ||||
ENC001238 | 0.885 | D01NTX | 0.338 | ||||
ENC000716 | 0.885 | D0T9TJ | 0.333 | ||||
ENC000381 | 0.872 | D0O1PH | 0.333 | ||||
ENC000446 | 0.854 | D05ATI | 0.330 |